unknown
Stage
About
Zehna Therapeutics is an early-stage biotech company developing small molecule inhibitors targeting gut microbial enzymes to treat chronic cardiometabolic diseases, with a lead focus on chronic kidney disease.
Explore Zehna Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.